Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Resveratrol (RSV) is a potential alternative therapy for non-alcoholic fatty liver disease (NAFLD) that has been evaluated in many clinical trials, but the mechanisms of RSV action have not been fully elucidated. Recent studies suggested that the gut microbiota is an important RSV target; therefore,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Microbiol
Main Authors: Du, Fan, Huang, Rongfeng, Lin, Dan, Wang, Yuying, Yang, Xiaohuang, Huang, Xiaoyun, Zheng, Biyun, Chen, Zhixin, Huang, Yuehong, Wang, Xiaozhong, Chen, Fenglin
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Microbiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7942199/
https://ncbi.nlm.nih.gov/pubmed/33708180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2021.611323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados